Sarcopenia with muscle wasting in hepatic cancer predicts therapeutic outcome after hepatic artery intervention
Sarcopenia may attenuate the efficacy of HAI plus lenvatinib on hepatitis B-related HCC with DM, and BMI, AFP and ALB are factors affecting the therapeutic effect.
Authors
- Yuejuan Liao
Publication Details
- Journal
- International Journal of Clinical Pharmacology and Therapeutics
- Published
- 2024-12-31
- DOI
- https://doi.org/10.5414/cp204698
- Citations
- 2
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.65